Internal Medicine, Rheumatology · San Luis Obispo, CA
NPI
1164464566
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1039 Murrary St, Suite 200
San Luis Obispo, CA, 93405
Phone (805) 781-0702
Groups this clinician bills Medicare through
Medicare paid, 2024
$7.1M
492,886 services
Medicare patients, 2024
944
Average age 74
Drug cost, 2024
$6.0M
3,837 prescriptions
Company payments, 2023
$24.34
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Barry Eibschutz was code J3262 (injection, tocilizumab, 1 mg), 200,670 times for 57 patients. In total Barry Eibschutz billed 492,886 services in 44 codes, and Medicare paid $7.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 200,670 | 57 | $4.68 | $939K |
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 61,300 | 21 | $3.63 | $222K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 54,600 | 50 | $8.52 | $465K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 44,450 | 75 | $33.86 | $1.5M |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 39,545 | 47 | $9.10 | $360K |
| J9312 Injection, rituximab, 10 mg | Office | 24,500 | 66 | $61.05 | $1.5M |
| J3245 Injection, tildrakizumab, 1 mg | Office | 10,000 | 26 | $107.14 | $1.1M |
| J0897 Injection, denosumab, 1 mg | Office | 9,180 | 96 | $20.47 | $188K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 5,880 | 16 | $24.93 | $147K |
| 96365 Intravenous Infusion, Hydration | Office | 1,407 | 250 | $51.31 | $72K |
| 99213 Office E&M - Established | Office | 1,285 | 679 | $69.04 | $89K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,280 | 18 | $0.10 | $132 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 845 | 498 | $12.77 | $11K |
| 96372 Injection Administration | Office | 800 | 190 | $11.19 | $8,950 |
| 96413 Chemotherapy Administration | Office | 377 | 84 | $106.84 | $40K |
By year: 2022 $7.1M for 418,181 services; 2023 $6.9M for 484,419 services; 2024 $7.1M for 492,886 services.
Medicare prescription drug claims, 2024
In 2024, the drug Barry Eibschutz prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 614 prescriptions and refills. In total Barry Eibschutz wrote 3,837 Medicare prescriptions that cost $6.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 614 | 1,076 | 134 | $14K |
| Prednisone Generic | 461 | 652 | 141 | $4,153 |
| Hydroxychloroquine Sulfate Generic | 417 | 977 | 104 | $20K |
| Leflunomide Generic | 224 | 485 | 60 | $16K |
| Alendronate Sodium Generic | 179 | 458 | 53 | $1,807 |
| Risedronate Sodium Generic | 130 | 337 | 37 | $11K |
| Teriparatide Generic | 126 | 135 | 16 | $349K |
| Colchicine Generic | 98 | 226 | 31 | $13K |
| Folic Acid Generic | 85 | 217 | 22 | $692 |
| Allopurinol Generic | 84 | 228 | 26 | $1,192 |
| Forteo Teriparatide | 81 | 89 | 14 | $390K |
| Enbrel Sureclick Etanercept | 75 | 88 | 12 | $646K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 66 | 66 | 11 | $1,536 |
| Orencia Clickject Abatacept | 52 | 80 | Under 11 | $477K |
| Pilocarpine Hcl Generic | 47 | 83 | 13 | $2,915 |
Brand drugs: 1,046 claims; generic drugs: 2,735 claims; opioid claims: 115.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Barry Eibschutz $24.34 ($24.34 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $24.34.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $24.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.